Less Ads, More Data, More Tools Register for FREE

Pin to quick picksI3 Energy Regulatory News (I3E)

  • This share is currently suspended. It was suspended at a price of 12.74
  • There is currently no data for I3E

Form 8.3 - I3E LN

3 Oct 2024 15:30

RNS Number : 8451G
Syquant Capital
03 October 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

I3 Energy PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

October 2, 2024

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES-Gran Tierra Energy Inc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.01p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

16,714,504

1.39%

 

 

(2) Derivatives (other than options):

3,228,249

0.26%

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

19,942,753

1.65%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.01p ordinary

0.01p ordinary

0.01p ordinary

0.01p ordinary

0.01p ordinary

 

CFD

CFD

CFD

CFD

CFD

 

increasing a long position

increasing a long position

increasing a long position

increasing a long position

increasing a long position

 

203,139

842,880

242,864

100,000

50,000

 

12.2 GBp

12.24 GBp

12.3 GBp

12.2985 GBp

12.28 GBp

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

October 3, 2024

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETQKNBDKBDDDKK
Date   Source Headline
28th Sep 202111:25 amRNSH1 2021 Earnings Webcast
27th Sep 20214:44 pmRNSPresentation
27th Sep 20217:00 amRNSInterim Report and Dividend Declaration
16th Sep 20217:00 amRNSNotice of Half Year 2021 Results and Webcast
15th Sep 20219:53 amRNSWarrant Exercise and Share Issuance
9th Sep 20217:00 amRNSOperational Update
2nd Sep 20213:59 pmRNSHolding(s) in Company
2nd Sep 20213:58 pmRNSHolding(s) in Company
23rd Aug 20217:00 amRNSClosing of Previously Announced Acquisition
16th Aug 20217:00 amRNSOperational and Financial Update
30th Jul 20216:16 pmRNSIssue of Share Options
29th Jul 20217:00 amRNSOperational Update
28th Jul 20214:58 pmRNSHolding(s) in Company
28th Jul 20214:57 pmRNSHolding(s) in Company
28th Jul 20214:55 pmRNSHolding(s) in Company
27th Jul 20213:05 pmRNSAdmission to Trading of Share Capital
26th Jul 202111:25 amRNSResult of General Meeting
15th Jul 20218:37 amRNSOperational Update
9th Jul 20214:38 pmRNSPosting of Shareholder Circular & Options Issuance
8th Jul 20217:01 amRNSNew Corporate Presentation
8th Jul 20217:00 amRNSDividend Declaration
7th Jul 20218:17 amRNSResults of Accelerated Bookbuild
7th Jul 20217:01 amRNSPrimaryBid Offer
7th Jul 20217:00 amRNSAlberta Acquisition and Proposed Placing
6th Jul 20214:40 pmRNSSecond Price Monitoring Extn
6th Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20217:00 amRNSOperational Update
1st Jul 20217:29 amRNSResult of AGM
30th Jun 20217:00 amRNSCapital Restructuring and Wapiti Acquisition
28th Jun 20217:00 amRNSOperational Update
17th Jun 20217:01 amRNSOperational & Dividend Update & Prod. Acquisition
17th Jun 20217:00 amRNSi3 Canada Ltd YE 2020 Reserves
3rd Jun 202111:53 amRNSResult of General Meeting
1st Jun 20219:05 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
1st Jun 20217:15 amRNSFinal Results for the year ended 31 December 2020
1st Jun 20217:00 amRNSSouth Simonette Consolidation – ROFR Exercise
18th May 20219:31 amRNSReduction of Capital
17th May 20217:00 amRNSContract Restructure & Dividend Creditor Consent
5th May 20217:00 amRNSOperational and Financial Update
29th Apr 20218:56 amRNSExercise of Options and Share Issuance
22nd Apr 20215:11 pmRNSHolding(s) in Company
16th Apr 20217:00 amRNSWarrant Exercise and Share Issuance
7th Apr 20213:49 pmRNSHolding(s) in Company
31st Mar 20217:00 amRNSOperational and Financial Update
23rd Mar 20213:15 pmRNSHolding(s) in Company
16th Mar 20213:17 pmRNSHolding(s) in Company
24th Feb 20219:05 amRNSSecond Price Monitoring Extn
24th Feb 20219:00 amRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.